1-866-647-3279

12

Nov 2026

NHP Quality Management in Canada: Why Compliance Doesn’t End with Product Licensing
NHP Quality Management in Canada: Why Compliance Doesn’t End with Product Licensing
By
At a Glance Obtaining a Natural Product Number (NPN) is an important milestone for companies marketing Natural Health Products (NHPs) in Canada, but regulatory compliance does not end when a […] Read More >>

10

Nov 2026

Novel Food Notifications in Canada: Requirements, Timelines, and Scientific Evidence
Novel Food Notifications in Canada: Requirements, Timelines, and Scientific Evidence
By
At a Glance Novel Food Notifications (NFNs) are required for foods and food ingredients classified as novel under Division 28 of Canada’s Food and Drug Regulations. Manufacturers and importers must […] Read More >>

10

Nov 2026

Health Canada Proposes New Shilajit Monograph for Natural Health Products
Health Canada Proposes New Shilajit Monograph for Natural Health Products
By
At a Glance Health Canada’s Natural and Non-Prescription Health Products Directorate (NNHPD) has launched a consultation on a proposed new monograph for Shilajit, a mineral-rich substance traditionally used in Ayurvedic […] Read More >>

10

Nov 2026

Health Canada Proposes Changes to Workout Supplement Monograph: What’s New?
Health Canada Proposes Changes to Workout Supplement Monograph: What’s New?
By
At a Glance Health Canada’s Natural and Non-Prescription Health Products Directorate (NNHPD) is consulting on proposed revisions to its existing Workout Supplements monograph. Rather than introducing an entirely new framework, […] Read More >>

06

Nov 2026

Outsourced Quality Assurance for NHP Companies: When Does It Make Sense?
Outsourced Quality Assurance for NHP Companies: When Does It Make Sense?
By
At a Glance Natural Health Product (NHP) companies in Canada must maintain appropriate quality assurance oversight, but they are not necessarily required to employ a full-time Quality Assurance Person (QAP). […] Read More >>

06

Nov 2026

Class III NHP Applications in Canada: Requirements, Timelines, and Evidence
Class III NHP Applications in Canada: Requirements, Timelines, and Evidence
By
At a Glance Class III Natural Health Product (NHP) applications in Canada require a more comprehensive regulatory assessment than Class I or Class II submissions. These applications generally involve products […] Read More >>

06

Nov 2026

How to Respond to a Health Canada Information Request Notice (IRN)
How to Respond to a Health Canada Information Request Notice (IRN)
By
At a Glance Receiving an Information Request Notice (IRN) from Health Canada does not automatically mean that a Natural Health Product (NHP) application has been rejected. An IRN identifies additional […] Read More >>

03

Nov 2026

Health Canada Publishes Guidance on Clinical Trials with Decentralized Elements: What Sponsors Need to Know
Health Canada Publishes Guidance on Clinical Trials with Decentralized Elements: What Sponsors Need to Know
By
At a Glance On October 27, 2026, Health Canada published its final Guidance for Clinical Trials with Decentralized Elements, providing regulatory direction for sponsors, investigators, and Contract Research Organizations (CROs) […] Read More >>

19

Oct 2026

What Happens When an NHP Batch Fails Quality Testing?
What Happens When an NHP Batch Fails Quality Testing?
By
At a Glance When a Natural Health Product (NHP) batch fails quality testing, manufacturers and importers must investigate the result, assess its potential impact on product safety and quality, and […] Read More >>

19

Oct 2026

What Does a Quality Assurance Person Do for Natural Health Products?
What Does a Quality Assurance Person Do for Natural Health Products?
By
At a Glance A Quality Assurance Person (QAP) is responsible for ensuring that Natural Health Products (NHPs) meet applicable quality requirements before they are made available for sale in Canada. […] Read More >>

19

Oct 2026

Can You Import NHPs into Canada Without Your Own Site Licence?
Can You Import NHPs into Canada Without Your Own Site Licence?
By
At a Glance Companies seeking to import Natural Health Products (NHPs) into Canada do not necessarily need to obtain their own Site Licence. Under Canada’s Natural Health Products Regulations, commercial […] Read More >>

16

Oct 2026

Health Canada Announces Interim Compliance Approach for NHP Monograph Labelling Updates
Health Canada Announces Interim Compliance Approach for NHP Monograph Labelling Updates
By
At a Glance Before Bulletin No. 13, Health Canada expected product licence holders to align labels affected by monograph revisions with the latest version of the monograph within three years […] Read More >>

09

Oct 2026

Bringing a Probiotic to Market in Canada: NHP, Food and Novel Food Pathways
Bringing a Probiotic to Market in Canada: NHP, Food and Novel Food Pathways
By
Abstract Bringing a probiotic product to market in Canada begins with determining how the finished product will be classified. Depending on its composition, dosage form, intended use, claims and overall […] Read More >>

05

Oct 2026

NHP GMP Inspections: What Importers Need to Demonstrate
NHP GMP Inspections: What Importers Need to Demonstrate
By
Abstract Good Manufacturing Practices (GMPs) establish the controls necessary to help ensure Natural Health Products (NHPs) are consistently manufactured, packaged, labelled, imported, distributed and stored in a manner that supports […] Read More >>

02

Sep 2026

How to Leverage a GRAS Dossier for Global Market Access
How to Leverage a GRAS Dossier for Global Market Access
By
At a Glance A GRAS dossier is often viewed as a regulatory submission prepared solely to support commercialization in the United States. In reality, a well-developed GRAS dossier can become […] Read More >>

21

Aug 2026

Health Canada Expands the List of Interchangeable Terms for NHP Labelling
Health Canada Expands the List of Interchangeable Terms for NHP Labelling
By
At a Glance Health Canada’s Natural and Non-prescription Health Products Directorate (NNHPD) has updated its List of Interchangeable Terms to provide greater flexibility when labelling Natural Health Products (NHPs) and […] Read More >>

19

Aug 2026

Clinical Supply Chain Oversight for Live Biotherapeutic Trials: Protecting Product Viability from Manufacturing to Patient
Clinical Supply Chain Oversight for Live Biotherapeutic Trials: Protecting Product Viability from Manufacturing to Patient
By
At a Glance Live Biotherapeutic Products (LBPs) are transforming therapeutic development, with clinical programs expanding across gastrointestinal disorders, metabolic disorders, immunology, oncology, and rare conditions. Unlike conventional pharmaceutical Read More >>

14

Aug 2026

What Is Vanessa’s Law and How Does It Impact Therapeutic Products in Canada?
What Is Vanessa’s Law and How Does It Impact Therapeutic Products in Canada?
By
At a Glance Vanessa’s Law, formally known as the Protecting Canadians from Unsafe Drugs Act, strengthened Health Canada’s authority to identify and respond to safety risks associated with therapeutic products […] Read More >>

14

Aug 2026

Postbiotics vs. Probiotics: Regulatory and Clinical Differences
Postbiotics vs. Probiotics: Regulatory and Clinical Differences
By
Abstract Probiotics and postbiotics are both increasingly used in microbiome-focused health products, but the regulatory and clinical considerations surrounding them can differ substantially. Probiotics depend on live microorganisms, making strain [&hellip Read More >>

14

Aug 2026

Health Canada Publishes New Guidance for Non-Prescription Drug Market Authorization in Canada
Health Canada Publishes New Guidance for Non-Prescription Drug Market Authorization in Canada
By
At a Glance Health Canada has released a new guidance document, How to apply for market authorization for a non-prescription drug in Canada, providing industry with its first comprehensive roadmap […] Read More >>

    Menu
    Online Learning
    Subscribe

    Stay up to date on regulatory and compliance updates, news, and events!

      © dicentra. All Rights Reserved.
      Privacy Statement | Terms & Conditions